Zhongxin Jingwei, January 8 - On January 8, the Shanghai Stock Exchange issued the "Decision on Giving Regulatory Warnings to Henan Xiangyu Medical Equipment Co., Ltd. and Relevant Responsible Persons" (hereinafter referred to as the "Regulatory Warning Decision").
*: Shanghai Stock Exchange**.
According to the facts ascertained by the Henan Securities Regulatory Bureau's "Decision on Issuing Warning Letters to Henan Xiangyu Medical Equipment Co., Ltd. and Related Personnel", Xiangyu Medical failed to disclose the litigation of contract disputes with Henan Wujian Construction Group in a timely manner, involving an amount of 2844780,000 yuan.
The Company's failure to disclose the litigation matters in a timely manner violated Article 5 of the Listing Rules of the Shanghai ** Stock Exchange on the Science and Technology Innovation Board (hereinafter referred to as the "Listing Rules of the Science and Technology Innovation Board").1.Article 1, Article 51.Article 2, Article 93.1 and other relevant provisions. He Yongzheng, chairman and general manager of the company, as the main person in charge of the company and the first person responsible for information disclosure, and Wei Zuoqin, then secretary of the board of directors, as the specific person in charge of information disclosure, failed to perform their duty of diligence and responsibility, and were mainly responsible for the company's above-mentioned violations.
In accordance with relevant regulations, the management department of the Science and Technology Innovation Board of the Shanghai Stock Exchange decided to give regulatory warnings to Xiangyu Medical, He Yongzheng and Wei Zuoqin.
Xiangyu Medical's 2022 annual report shows that He Yongzheng, born in 1972, is a senior economist, a senior engineer, Chinese nationality, no right of permanent residence abroad, an expert in municipal management of Anyang City, a leading talent in the Central Plains industry innovation, and enjoys the ** special allowance in Henan Province. He is a member of the 13th Committee of the Henan Provincial Committee of the Chinese People's Political Consultative Conference, a member of the Standing Committee of the 15th People's Congress of Anyang City, a vice chairman of the Anyang Federation of Industry and Commerce, a distinguished professor and doctoral supervisor of Zhengzhou University, a master's supervisor of Zhongyuan Institute of Technology, and an off-campus graduate tutor of Xi'an Jiaotong University. In 2002, he founded Siangyu Medical and is currently the chairman, general manager and technical director of the company. Since 2015, he has served as the executive director of Henan Xianghe ** Industrial Technology Research Institute Co., Ltd.
Wei Zuoqin, born in 1978, bachelor degree, Chinese nationality, no right of permanent residence abroad. He used to be the head of the audit department, the deputy director of the legal department, the deputy director of the investment and legal affairs center, and the affairs representative of Henan Tailong Pharmaceutical Co., Ltd. He joined Siangyu Medical in July 2021 and successively served as the director of the office of the board of directors, the representative of ** affairs, the deputy general manager and the secretary of the board of directors.
According to the official website, Siangyu Medical was founded in 2002 and listed on the Science and Technology Innovation Board in March 2021. The company mainly provides a full range of first-class products and overall solutions for customers at all levels of general hospitals, first-class hospitals, primary diagnosis and treatment institutions and other medical institutions at all levels across the country, elderly care institutions, first-class centers for the disabled, and welfare institutions.
In terms of performance, Siangyu Medical achieved revenue of about 54.2 billion yuan, a year-on-year increase of 5199%；The net profit attributable to shareholders of the listed company was about 17.9 billion yuan, a year-on-year increase of 9283%。
In the secondary market, Xiangyu Medical closed down 1 on January 859% to 4955 yuan shares, the total market value is 79$2.8 billion. (Zhongxin Jingwei app).
For more exciting content, please pay attention to the official WeChat of JWVIEW***